Canada
· Delayed Price · Currency is CAD Numinus Wellness Company Description
Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States.
The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments.
The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies.
The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services.
The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services.
The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services.
The company was incorporated in 1964 and is headquartered in Vancouver, Canada.
| Country | Canada |
| Founded | 1964 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Payton Nyquvest |
Contact Details
Address: 666 Burrard Street Vancouver, British Columbia V6C 2X8 Canada | |
| Phone | 833 686 4687 |
| Website | numinus.com |
Stock Details
| Ticker Symbol | NUMI |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | September - August |
| Reporting Currency | CAD |
| ISIN Number | CA67054W1032 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Payton Nyquvest | Founder, Chief Executive Officer and Chairman |
| Michael Tan M.B.A. | President, Chief Operating Officer and Director |
| Dr. Paul Thielking M.D. | Chief Science Officer |
| Dr. Reid J. Robison M.D., MBA | Chief Clinical Officer |
| Melony Valleau CPA | Interim Chief Financial Officer |
| Jamie Kokoska | Vice President of Investor Relations |
| Paula Amy Hewitt | Senior Vice President, General Counsel and Chief Privacy Officer |
| Ian Noble | Chief Communications Officer |
| Danielle Hinan | Vice President Marketing |
| Lea Bottoni | Vice President of People and Culture |